Vitamin D deficiency and its relationship to cancer stage in patients who underwent thyroidectomy for papillary thyroid carcinoma.

作者: Anita Sulibhavi , Matthew L. Rohlfing , Scharukh M. Jalisi , David B. McAneny , Gerard M. Doherty

DOI: 10.1016/J.AMJOTO.2019.04.013

关键词:

摘要: Abstract Purpose As imaging technology improves and more thyroid nodules malignancies are identified, it is important to recognize factors associated with malignancy poor prognosis. Vitamin D has proven useful as a prognostic tool for other cancers may be similarly in cancer. This study explores the relationship of papillary carcinoma stage while accounting socioeconomic covariates. Materials methods The medical records all patients who underwent thyroidectomy at one institution between 2000 2015 were reviewed. Subjects non-papillary cancer pathology, prior malignancy, without levels excluded. remaining 334 patient examined stage, levels, deficiency listed history, demographic comorbid factors. Results laboratory values showed no significant (p = 0.871), but documented record likely have advanced disease (28.6% versus 14.7%; p = 0.028). also had lower 25-hydroxyvitamin nadirs (21.5 ng/mL 26.5 ng/mL, p = 0.008) on supplementation (92.6% 41.8%, p  Conclusions results suggest that value negative indicator pre-operative evaluation less useful. because modifiable. While different racial subgroups rates deficiency, neither race nor status correlation stage.

参考文章(21)
Linda S. Kahn, Nikhil Satchidanand, Anil Kopparapu, Winston Goh, Sandra Yale, Chester H. Fox, High prevalence of undetected vitamin D deficiency in an urban minority primary care practice. Journal of The National Medical Association. ,vol. 103, pp. 407- 411 ,(2011) , 10.1016/S0027-9684(15)30337-0
Joseph Tangrea, Kathy Helzlsouer, Pirjo Pietinen, Philip Taylor, Bruce Hollis, Jarmo Virtamo, Demetrius Albanes, Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men Cancer Causes & Control. ,vol. 8, pp. 615- 625 ,(1997) , 10.1023/A:1018450531136
Stephen B. Edge, Carolyn C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM Annals of Surgical Oncology. ,vol. 17, pp. 1471- 1474 ,(2010) , 10.1245/S10434-010-0985-4
S Greenland, Modeling and variable selection in epidemiologic analysis. American Journal of Public Health. ,vol. 79, pp. 340- 349 ,(1989) , 10.2105/AJPH.79.3.340
Vibha Sharma, Deborah Fretwell, Zachary Crees, Anna Kerege, Joshua P. Klopper, Thyroid Cancer Resistance to Vitamin D Receptor Activation Is Associated with 24-Hydroxylase Levels But Not the ff FokI Polymorphism Thyroid. ,vol. 20, pp. 1103- 1111 ,(2010) , 10.1089/THY.2010.0096
ChandraKanti Chakraborti, Vitamin D as a promising anticancer agent. Indian Journal of Pharmacology. ,vol. 43, pp. 113- 120 ,(2011) , 10.4103/0253-7613.77335
Laura Vuolo, Carolina Di Somma, Antongiulio Faggiano, Annamaria Colao, Vitamin D and Cancer Frontiers in Endocrinology. ,vol. 3, pp. 58- 58 ,(2012) , 10.3389/FENDO.2012.00058
Mariko MORISHITA, Akira OHTSURU, Atsushi KUMAGAI, Hiroyuki NAMBA, Noriko SATO, Tomayoshi HAYASHI, Shunichi YAMASHITA, Vitamin D3 Treatment for Locally Advanced Thyroid Cancer: A Case Report Endocrine Journal. ,vol. 52, pp. 613- 616 ,(2005) , 10.1507/ENDOCRJ.52.613
S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E. J. Mutschelknauss, D. Flesch-Janys, J. Chang-Claude, Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study. Carcinogenesis. ,vol. 29, pp. 93- 99 ,(2007) , 10.1093/CARCIN/BGM240